ALLIANCEBERNSTEIN L.P. - LEGEND BIOTECH CORP ownership

LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of LEGEND BIOTECH CORP
ValueSharesWeighting
Q3 2023$74,013,347
-25.6%
1,101,881
-23.5%
0.03%
-24.4%
Q2 2023$99,464,775
+30.7%
1,440,892
-8.7%
0.04%
+24.2%
Q1 2023$76,088,604
+18.0%
1,577,947
+22.2%
0.03%
+13.8%
Q4 2022$64,481,564
+2.9%
1,291,698
-15.9%
0.03%
-3.3%
Q3 2022$62,680,000
-22.2%
1,536,271
+4.8%
0.03%
-18.9%
Q2 2022$80,609,000
+6.7%
1,465,620
-29.5%
0.04%
+27.6%
Q1 2022$75,543,000
-20.1%
2,078,775
+2.5%
0.03%
-12.1%
Q4 2021$94,506,000
-6.5%
2,027,599
+1.5%
0.03%
-17.5%
Q3 2021$101,026,000
+29.7%
1,998,150
+5.3%
0.04%
+29.0%
Q2 2021$77,871,000
+26.6%
1,896,983
-10.5%
0.03%
+14.8%
Q1 2021$61,531,000
+77.7%
2,120,291
+72.5%
0.03%
+68.8%
Q4 2020$34,622,000
-18.9%
1,229,459
-11.1%
0.02%
-30.4%
Q3 2020$42,707,000
-6.4%
1,383,439
+29.0%
0.02%
-14.8%
Q2 2020$45,641,0001,072,4000.03%
Other shareholders
LEGEND BIOTECH CORP shareholders Q3 2023
NameSharesValueWeighting ↓
FengHe Fund Management Pte. Ltd. 997,714$36,257,00013.28%
JOHNSON & JOHNSON 1,629,173$59,204,00011.19%
Paradigm Biocapital Advisors LP 831,728$30,225,0007.99%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,100,542$39,994,0005.54%
HHLR ADVISORS, LTD. 6,936,617$252,077,0005.26%
Old Well Partners, LLC 79,700$2,896,0001.94%
Parkman Healthcare Partners LLC 120,473$4,378,0001.28%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 4,500$5,632,0001.27%
AtonRa Partners 50,928$1,851,0001.00%
Avidity Partners Management LP 1,095,000$39,792,0000.83%
View complete list of LEGEND BIOTECH CORP shareholders